Mutations in PKD1 and PKD2, the genes that encode polycystin-1 and polycystin-2 respectively, account for almost all cases of Autosomal Dominant Polycystic Kidney Disease.
INTRODUCTION
Autosomal Dominant Polycystic Kidney Disease (ADPKD) 1 is one of the most common monogenetic diseases of man, with an incidence rate of approximately 1:500 to 1:1000 in the general population (1) . Mutations in two genes account for almost all cases of ADPKD. PKD1, which encodes polycystin-1, is mutated in approximately 85% of patients, while PKD2, which encodes polycystin-2, is mutated in 10-15% of patients (2) .
Both polycystins are predicted to be transmembrane proteins with cytoplasmic Cterminal tails (3, 4) . Polycystin-1 is believed to play a role in cell-cell or cell-matrix interactions, renal tubulogenesis, and intracellular signaling pathways (via its C-terminal tail) (5) (6) (7) (8) (9) (10) . Polycystin-2 has also been implicated in intracellular signaling pathways, and has been shown to have calcium channel activity (11) (12) (13) (14) (15) . A recent study in kidney epithelial cells suggests that both polycystins may also play a role in cilium mechanosensation (16) .
Several lines of evidence indicate that polycystin-1 and polycystin-2 interact within the Polycystin-2 Modulates Polycystin-1 Distribution cell. Mutations in either mammalian PKD1 or PKD2, or the C. elegans homologues of these genes, result in almost identical phenotypes, suggesting that the polycystins are part of the same biochemical pathway (17, 18) . Additionally, the C-terminal regions of both proteins have been shown to interact in both in vitro and in vivo assays (19, 20) . Finally, two recent reports have suggested that polycystin-1 and polycystin-2 may form a functional complex within intact cells (21, 22) . Despite these observations, little is still known about the precise nature of the relationship between the polycystins in the cell, especially in terms of the effect each has on the other's subcellular distribution. Polycsytin-1 is predominantly found in the plasma membranes of cells in culture and in tissues, although some groups also detect it in the cytoplasm in association with intracellular membranes. There is less consensus about the subcellular localization of polycystin-2. Several groups have localized it to the endoplasmic reticulum and Golgi, while others have found it in the plasma membrane (reviewed in 23, 24) . In addition, the expression patterns of both proteins are often inversely related during development, and polycystin-1 has been shown to relocate from the plasma membrane to the cell interior as an organism matures (25) . This information is difficult to reconcile with the models favoring interaction of the polycystins, as one would expect that two interacting proteins would manifest similar patterns of expression and localization.
In an effort to resolve these issues, we have chosen to focus on the localization patterns of polycystin-1 and polycystin-2 in cultured cells. We find that when full-length polycystin-1 is Polycystin-2 Modulates Polycystin-1 Distribution expressed alone in a cell line that does not express polycystin-2, it localizes to the cell surface and ER. However, when polycystin-1 is co-expressed with polycystin-2 in the same cell line, it is not found at the cell surface. Rather, it is seen exclusively inside the cell, where it colocalizes with polycystin-2 in the ER. Further experiments, in which the C-terminal tail of polycystin-1 is expressed in COS-7 cells as part of a membrane-anchored fusion protein, confirm that the subcellular localization of polycystin-1 depends on the ratio of polycystin-2 to polycystin-1 expression. Our data are consistent with a titration effect, whereby the localization of polycystin-1 within the cell can be regulated via the relative expression level of polycystin-2.
This effect may explain many of the inconsistencies that have been reported in the expression and localization patterns of the polycystins, and may suggest a mechanism whereby the functions of these proteins are regulated during development.
EXPERIMENTAL PROCEDURES

Constructs
The PKD1-FL construct is a modification of a full-length mouse PKD1 construct (PKD1-HA) in pcDNA3.1 (Invitrogen). PKD1 cDNA fragments were generated via RT-PCR on mouse kidney mRNA. The full-length cDNA was assembled by subcloning these fragments together, and a triple HA tag was inserted in frame directly upstream of the stop codon. The PKD1-HA construct was confirmed by direct sequencing, and expression of the construct was demonstrated via anti-HA western blotting and immunofluorescence. This vector was cut with XbaI (New England Biolabs), and a partial digest was performed with Eco47-III (Fermentas) to produce an Polycystin-2 Modulates Polycystin-1 Distribution 18.5 kb fragment. An oligo encoding the first 27 amino acids of polycystin-1 (including the initiator methionine and the predicted N-terminal signal peptide cleavage site) followed by a triple FLAG tag was then cloned into these sites. To create PKD1-W, a cDNA encoding the Cterminal 112 amino acids of Polycystin-1 was subcloned into the HindIII and NotI sites of Bluescript (Stratagene), downstream of the extracellular domain of placental alkaline phosphatase (PLAP) (gift of S. Udenfriend, Roche Institute of Molecular Biology) and the transmembrane region of the vesicular stomatitis virus major coat glycoprotein (VSV-G).
PKD1-W was then subcloned into the KpnI and NotI sites of either pcDNA3.1 or KRSPA (gift of R. Marienfeld, Yale University) vector to create the PKD1-W(3) and PKD1-W(K) constructs, respectively. A cDNA encoding the final 49 amino acids of the GABA transporter, GAT-2, was similarly subcloned with PLAP and VSV G into pCB6 (gift of M. Roth, University of Texas Southwestern) to create the PLAP-GAT2 construct. All constructs were confirmed by direct sequencing. Creation of PKD2-FL construct has been described previously (26) .
Isolation of PKD2 -/-Cells
The cell isolation procedure utilized is a modification of that devised by Van Adelsberg et al. (27) . Kidneys from a PKD2 WS25/-mouse transgenic for the SV40 Large T Antigen were (19) . Protein-G beads (Pierce), pre-incubated with anti-PLAP monoclonal antibody (1:100 dilution), were combined with the soluble fraction of the cell lysate and rotated overnight at 4° C. Beads were pelleted and washed three times with Co-Ip buffer, and bound protein was eluted with Laemmli buffer.
Pixel Intensity Measurements
Cos-7 cells transiently transfected with PKD1-W(3) or PLAP-GAT2, and PKD2-FL were subjected to the triple labeling IF protocol described above. Individual cells were chosen at random, and intensity values for each fluorescence channel were obtained. Our group has shown that the average fluorescence intensity of the Jackson Labs anti-mouse Cy5 conjugated Fab secondary antibody is 1.4 times that of the anti-mouse FITC conjugated Fab secondary when used to detect the same concentration of monoclonal anti-PLAP primary antibody. Thus, all
Cy5 intensity values obtained in our pixel intensity study were multiplied by 0.7 so that they could be directly compared to the FITC intensity values. The corrected Cy5 pixel intensity value represents the total amount of PLAP fusion protein at the cell surface, while the FITC value represents the total amount of PLAP fusion protein inside the cell. The Rhodamine value represents the entire cellular population of polycystin-2. The total PLAP fusion protein expression per cell was obtained by adding the corrected Cy5 value to the FITC value.
"high" -depending on whether they fell within the bottom, middle, or upper third, respectively, of the Rhodamine intensity values collected for all cells.
RESULTS
Polycystin-2 Expression Influences the Localization of Polycystin-1 in a Mouse Proximal Tubule Cell Line
To ascertain what role polycystin-2 plays in modulating the subcellular distribution of polycystin-1, a vector encoding the full-length sequence of murine polycystin-1 with an extracellular N-terminal triple FLAG tag and an intracellular C-terminal triple HA tag (PKD1-FL) was transfected into a PKD2 null cell line. This cell line was derived from the proximal tubule of a PKD2 WS25/-mouse, and has been shown to carry a genomic rearrangement on the WS25 allele that results in PKD2 -/-cells (29, 30 , and unpublished data). A western blot of total PKD2 -/-cell lysate confirmed the absence of polycystin-2 expression in this cell line. In contrast, polycystin-2 expression was detected in lysates prepared from a related PKD2 WS25/-cell line that had undergone a WS25 rearrangement to the wild-type PKD2 allele (PKD2 +/-) as well as from a PKD2 -/-cell line transfected with a vector encoding the full-length sequence of polycystin-2 (PKD2-FL) ( Fig. 2A) . In order to detect polycystin-1 at the surface of the PKD2 -/-cells, live cells were incubated with an anti-FLAG monoclonal antibody. This was followed by incubation with an anti-mouse Cy5 conjugated Fab secondary antibody at a concentration sufficient to completely saturate the bound FLAG antibody and hence prevent any further binding of anti-mouse secondary antibody (blocking concentration). Both steps were carried out at 4°C to prevent antibody internalization. Cells were then fixed and permeabilized, and intracellular polycystin-1 was detected via incubation in an anti-FLAG monoclonal antibody and an anti-mouse FITC conjugated Fab antibody at room temperature. Thus, fluorescent staining visualized on the Cy5 channel revealed the surface population of polycystin-1, while staining on the FITC channel corresponded to the entire intracellular population of the protein.
In PKD2 -/-cells transfected with PKD1-FL alone, polycystin-1 localized to the plasma membrane, as well as to cytoplasmic and perinuclear structures (Fig. 2B) . The intracellular pool of polycystin-1 co-localized with the ER-marker calnexin (Fig. 2C) .
To ensure optimal detection of polycystin-2, antibodies specific for both the N and C (26) were combined for use in immunofluorescence studies. When PKD2-FL was transfected into the PKD2 -/-cells, polycystin-2 localized to perinuclear and cytoplasmic structures, which also stained for calnexin (Fig. 2C ). This expression pattern was identical to that of endogenous polycystin-2 in PKD2 +/-cells (data not shown). When PKD1-FL and PKD2-FL were co-transfected into the PKD2 -/-cells, polycystin-1 co-localized exclusively with polycystin-2 in the ER and was not detected at the cell surface (Fig. 2B) . These results led us to hypothesize that polycystin-2 may play a role in determining the subcellular distribution of polycystin-1.
Design of Relatively High and Low Expressing PKD1 Constructs
As most cells express at least low endogenous levels of polycystin-2, we decided to examine whether the relative level of polycystin-2 to polycystin-1 expression determines the subcellular localization of polycystin-1. For this purpose, we utilized COS-7 cells, which express endogenous polycystin-2 and can be transfected at a much higher efficiency than the PKD2 -/-cells.
The large size of full-length polycystin-1 precludes it from being expressed at high levels from the PKD1-FL vector. In an effort to obtain a wider range of polycystin-1 expression, we created a fusion protein, polycystin-1w, which includes the final 112 amino acids of the C-terminus of polycystin-1. This portion of polycystin-1 has been shown to participate Varied levels of expression of polycystin-1w were achieved by subcloning the cDNA encoding it (PKD1-W) into two separate vectors: PCDNA3.1, which contains a CMV promoter that drives strong expression, and KRSPA, which contains a weaker RSV promoter. This resulted in the constructs PKD1-W(3) and PKD1-W(K), respectively. To determine the relative polycystin-1w expression level of these constructs, each construct was transfected into duplicate sets of COS-7 cells. The average number of transfected cells was determined via immunofluorescence on one set of cells, while the total quantity of fusion protein expressed was determined via densitometry analysis on a western blot of the total cell lysate from the other set of cells. The densitometry figure divided by the immunofluorescence figure gave a value proportional to the average expression of each construct per transfected cell. In this manner, we were able to demonstrate that, on average, approximately 6 times more polycystin-1w per transfected cell is expressed from PKD1-W(3) than from PKD1-W(K) (Fig. 3A) .
Polycystin-1w Localizes to the Plasma Membrane and Endoplasmic Reticulum
Live COS-7 cells transiently transfected with PKD1-W(3) or PKD1-W(K) were incubated at 4°C with an anti-PLAP monoclonal antibody, followed by a blocking concentration of anti-mouse Cy5 conjugated Fab secondary antibody. Cells were then permeabilized and incubated in anti-PLAP monoclonal and anti-mouse FITC conjugated Fab secondary antibodies. This protocol allowed us to distinguish the polycystin-1w population at the cell surface from that inside the cell. As with the full-length polycystin-1 protein, polycystin-1w was detected at the plasma membrane and in cytoplasmic and perinuclear structures within the cell (Fig. 3B) . However, cells transfected with PKD1-W(3) displayed markedly higher levels of surface expression than those transfected with PKD1-W(K). COS-7 cells transfected with PLAP-GAT2 displayed strong surface and little intracellular staining of the PLAP-GAT2 fusion protein (Fig. 3B) . The nature of the cytoplasmic and perinuclear structures seen with polycystin-1w expression was determined by double-labeling COS-7 cells transiently transfected with PKD1-W(3) or PKD1-W(K) with antibodies directed against PLAP and calnexin. Polycystin-1w co-localized with calnexin in the cytoplasmic and perinuclear structures, indicating that the intracellular population of polycystin-1w is associated with the ER. In many cells, polycystin-1w expression from the PKD1-W(3) construct also displayed a fibrous cage-like pattern (Fig. 4) . This pattern has been reported previously, and was interpreted as an interaction of polycystin-1 with intermediate filaments (33) . Polycystin-2, when expressed exogenously in COS-7 cells, also localized to perinuclear and cytoplasmic structures. Co-localization studies with calnexin revealed that this expression pattern was consistent with an ER localization (Fig. 4) .
Polycystin-2 Interacts Specifically with Polycystin-1w
As polycystin-1w and polycystin-2 appeared to localize to the same intracellular compartment, we performed a co-immunoprecipitation assay to determine whether these two proteins are capable of interacting within the cell. Protein G beads were pre-incubated with a monoclonal anti-PLAP antibody and exposed to the total cell lysate of COS-7 cells co-transfected with PKD2-FL and PKD1-W(3), PKD1-W(K), or PLAP-GAT2. After washing to remove nonspecifically associated polypeptides, material bound to the protein G beads was eluted, separated by SDS-PAGE, and transferred to a western blot. Blots probed with an anti-PLAP polyclonal antibody indicated that all of the PLAP-VSV G fusion proteins were effectively immunoprecipitated by the protein G / anti-PLAP beads. However, blots probed with antipolycystin-2 antibodies demonstrated that only polycystin-1w, when expressed from either PKD1-W construct, was capable of co-immunoprecipitating with polycystin-2 (Fig. 5) . These results indicate that polycystin-1w and polycystin-2 can form a stable and specific cellular interaction.
The Ratio of Polycystin-2 to Polycystin-1w Expression Influences the Subcellular Localization of Polycystin-1w in a Population of COS-7 Cells
To determine the effect of polycystin-2 expression on polycystin-1w localization, COS-7 cells were transiently co-transfected with PKD2-FL and PKD1-W(3), or PKD2-FL and PKD1-W(K). The relative protein expression level associated with each construct was calculated as described earlier. When PKD1-W(K) was co-transfected with PKD2-FL, the ratio of polycystin-2 to polycystin-1w expression per transfected cell was approximately 4 times greater than when PKD1-W(3) was co-transfected with PKD2-FL (Fig. 6A) . Triple labelimmunofluorescence performed on these cells allowed us to determine how these ratios influence the subcellular localization of polycystin-1w. The protocol for this technique is outlined in Figure 1 .
Cells co-transfected with PKD2-FL and either PKD1-W construct displayed strong co-localization between polycystin-1w and polycystin-2 in the ER (Fig. 6B) , supporting the results of the co-immunoprecipitation assay. In addition, 44 ± 2.8% of the cells transfected with PKD1-W(3) displayed polycystin-1w at the cell surface. However, in cells transfected with PKD1-W(K), polycystin-1w was largely restricted to the ER and was only found at the cell surface of 18 ± 1.0% of these cells (p <.01).
PLAP-GAT2 was found at the cell surface in 99 ± 0.7% of cells co-transfected with polycystin-2, and there was no evidence of co-localization between the two proteins (Fig. 6, A and B) . The overall trend we observed indicates that, in a population of cells, a high polycystin-2 to polycystin-1w expression ratio results in a substantially smaller fraction of cells with polcystin1w at the cell surface than does a low polycystin-2 to polycystin-1w ratio.
Polycystin-1w Localization is a Function of Polycystin-2 Expression in Individual COS-7 Cells
Because the biochemical measurement of polycystin-2 to polycystin-1w expression levels provided us with quantitative information for a population of cells only, we developed an assay to directly measure the relative levels of polycystin-1w and polycystin-2 expression in individual cells. Triple antibody labeling, as described in Figure 1 , was carried out on COS-7 cells transiently co-transfected with PKD2-FL, and PKD1-W(3) or PLAP-GAT2 .
This triple label protocol allowed us to effectively distinguish the PLAP-VSV G fusion protein population at the cell surface (Cy5 signal) from that inside the cell (FITC signal). The entire polycystin-2 population was represented by the rhodamine signal. The absolute pixel intensity associated with each fluorescence channel was quantitated for every cell analyzed in a randomly selected sample of cells. In a separate experiment, it was determined that the Cy5 conjugated Fab secondary antibody exhibits a fluorescence intensity approximately 1.4 times that of FITC conjugated Fab secondary antibody for the same PLAP epitope concentration under the same conditions (data not shown). Thus, all Cy5 intensity figures were multiplied by 0.7 so that they could be normalized against the FITC figures. Using this approach, we were able to quantitate the cellular ratio of polycystin-2 to polycystin-1w expression, and to determine how this relationship affected the localization of polycystin-1w in individual cells.
In COS-7 cells co-transfected with PKD1-W(3) and PKD2-FL, a clear hyperbolic trend was observed (Fig. 7A) . As the relative amount of total polycystin-2 to total polycystin-1w expression increased, a smaller percentage of the polycystin-1w population was found at the cell surface. At high levels of polycystin-2 to polycystin-1w expression, no polycystin-1w was found at the cell surface. This relationship was not dependent upon the total level of polycystin-2 expression, as points representing cells expressing relatively high (red dots), moderate (orange dots), or low (yellow dots) levels of polycystin-2 expression were distributed randomly throughout the plot. Thus, the ratio of polycystin-2 to polycystin-1w expression, rather than the absolute amount of polycystin-2 present, determined the localization of polycystin-1w. This trend was not seen in cells co-transfected with PLAP-GAT2 and PKD2-FL, where the relative expression level of polycystin-2 to PLAP-GAT2 did not appear to influence the surface localization of PLAP-GAT2 (Fig. 7B) . We also observed that only 21 ± .02% of Our data also indicate that polycystin-2 is an ER-resident protein, and that its distribution is not altered by the presence of full-length polycystin-1 or by the level of polycystin-1w expression. This ER localization pattern has been documented in both cell culture systems and in native tissues by several groups. Most recently, Koulen et al. have shown, via biochemical and cell fractionation studies, that the majority of the polycystin-2 population in native kidney is localized to the ER, and does not appear to traffic beyond the medial Golgi stacks (14) . In contrast, an immunofluorescence study performed on CHO cells permeabilized prior to polycystin-1 and polycystin-2 detection suggests that co-expression of full length polycystin-1 and polycystin-2 produces an apparent cell surface distribution for polycystin-2 (21) . This discrepancy with our results and with the findings of others may be attributable to differences between the cell lines employed or to the absolute levels of full-length polycystin-1 expression achieved in these studies. Newby et al., utilizing PKD1 transgenic kidney cells, have also suggested that polycystin-1 and polycystin-2 form a complex in the plasmalemma (22) . Immunofluorescence and cosedimentation studies performed by this group, however, suggest that the majority of the polycystin-2 population is restricted to the ER and Golgi. Furthermore, their data does not exclude the presence of a polycystin-1 -polycystin-2 interaction that may occur across adjacent ER and plasma membranes, and not within the plane of the plasmalemma itself. Finally, a report by Luo et al. indicates that polycystin-2 is present in the plasma membrane of renal epithelia (15) . However, half of the renal cell lines surveyed in the study displayed a strong intracellular localization for polycystin-2 and little to no polycstyin-2 expression at the cell surface. It must be noted that we cannot rule out the presence of a small population of polycystin-2 at the plasma membrane, which may be below our level of detection. In addition, we and others have observed polycystin-2 in the primary cilium (data not shown, and 16, 18, 34, 35) . Further work will be required to determine whether this population plays a role in modulating the distribution of a subpopulation of polycystin-1.
The results presented in this study are particularly interesting when considered in the context of kidney development. Several investigations have shown that the levels and patterns of polycystin-1 and polycystin-2 expression can vary dramatically during development, and are often inversely related. Overall, a general trend of early and intense polycystin-1 expression that decreases and becomes more restricted with development, and early moderate expression of polycystin-2 that often increases and becomes more diffuse with development has been reported (reviewed in 23, 24) . The consequences of these differences in expression for the localization of the polycystins have not yet been extensively studied. However, a report by Van Adelsberg et al. demonstrates that the polycystin-1 population shifts from the plasma membrane to the cytoplasm as kidney tubules mature (25) . Several groups have also shown that polycystin-1 is predominantly intracellular in cystic tissue, where polycystin-2 Polycystin-2 Modulates Polycystin-1 Distribution expression is often high (36) (37) (38) . These results are consistent with the observations from our expression studies.
In the context of the work presented here, the varying expression levels of polycystin-2 relative to polycystin-1 may represent a mode of regulating polycystin-1 localization during development. This may be particularly relevant, if, as some have speculated, polycystin-1 has a multifunctional role within the cell (22, 33, 39) .
The particular function of polycystin-1 in any given setting might depend on its subcellular localization. The extracellular region of the protein has homology to domains involved in cell-cell adhesion (4) . As cells begin to proliferate and differentiate, polycystin-1 expression decreases. Presumably, as a consequence of this, there is less of the protein at the cell surface. Our studies indicate that this condition could be replicated via an up-regulation of polycystin-2 expression, as is seen in developing kidneys. This increase in polycystin-2 levels could effectively "trap" polycystin-1 in the ER. Here, polycystin-1 may perform other functions, perhaps serving as a regulator of the polycystin-2 channel activity -a role that may become more important as an organism matures. Alternatively, if it is only active at one location, altering the localization of polycystin-1 may be a means for the cell to turn the function of the protein "on" or "off." At least one study has demonstrated that polycystin-1 is frequently found intracellularly in cells that do not participate in cell-cell interactions, and at the plasma membrane of cells that do engage in such interactions (39) . In addition, we have shown that only approximately 20% of the total population of polycystin-1 reaches the cell surface at its highest levels of surface expression, and Newby et al. have demonstrated that a mere 10% of the polycystin-2 present within the cell interacts with polycystin-1 (22) . Taken together, these results indicate that polycystin-1 likely has multiple binding partners and sites of activity within the cell, resulting in diverse functions for this protein.
Mice overexpressing human polycystin-1 develop cysts, as do PKD2 WS25/-mice that undergo a genetic rearrangement resulting in the loss of polycystin-2 expression (40). This observation can be explained in terms of our titration model. Abnormally high expression of polycystin-1 relative to that of polycysitn-2 may overwhelm polycystin-2's ability to "buffer" polycystin-1 localization. As a result, polycystin-1 may constitutively localize to the cell surface, and its intended function there would be exaggerated. A similar situation might be expected in a polycystin-2 null cyst, if polycystin-1 is still expressed at normal levels. Some of the naturally occurring disease-causing mutations in PKD1 and PKD2 have been shown to abrogate the ability of the polycystins to interact (20). These mutations may alter the functional balance between the two proteins and cause similar defects in the ability of polycystin-2 to regulate polycystin-1's localization.
The work presented here lends further credence to the hypothesis that polycystin-1 and polycystin-2 interact within the cell, and demonstrates a role for this interaction in determining the localization of polycystin-1 within the cell. The interplay between the expression level and localization of the polycystins may explain the complex and conflicting expression patterns documented in previous studies. In addition, this analysis may provide clues as to how alterations in the cellular ratio of polycystin-2 to polycystin-1 protein levels are involved in the pathogenesis of ADPKD. 
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